28530 Federal Register / Vol. 66, No. 100 / Wednesday, May 23, 2001 / Notices

Place: 31 Center Drive, Bldg. 31, Conf. Rm.

10, Bethesda, MD 20892.

Contact Person: Janice C. Ramsden,

Committee Mgmt. Officer, Office of the

Director, NIH, Building 1, Room 333,

Bethesda, MD 20892, 301–496–0959.

Information is also available on the

Institute’s/Center’s home page: http://

www.nih.gov/about/director/acd.htm, where

an agenda and any additional information for

the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.14, Intramural Research

Training Award; 93.187, Undergraduate

Scholarship Program for individuals from

Disadvantaged Backgrounds; 93.22, Clinical

Research Loan Repayment Program for

Individuals from Disadvantaged

Backgrounds; 93.232, Loan Repayment

Program for Research Generally; 93.39,

Academic Research Enhancement Award;

93.936, NIH Acquired Immunodeficiency

Syndrome Research Loan Repayment

Program, National Institutes of Health, HHS)

Dated: May 15, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–12914 Filed 5–22–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Office of the Director, National

Institutes of Health; Notice of Meeting

Pursuant to section 10(a) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

Secretary’s Advisory Committee on

Xenotransplantation.

The meeting will be open to the

public, with attendance limited to space

available. Individuals who plan to

attend and need special assistance, such

assign language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

Name of Committee: Secretary’s Advisory

Committee on Xenotransplantation.

Date: July 2–3, 2001.

Time: July 2, 2001, 8:30 a.m. to 5:30 p.m.

Agenda: Infectious disease issues in

xenotransplantation.

Place: Holiday Inn Bethesda, 8120

Wisconsin Avenue, Bethesda, MD 20814.

Time: July 2, 2001, 7:30 p.m. to 9 p.m.

Agenda: Infectious disease issues in

xenotransplantation.

Place: Holiday Inn Bethesda, 8120

Wisconsin Avenue, Bethesda, MD 20814.

Time: July 3, 2001, 8:30 a.m. to 2:00 p.m.

Agenda: Infectious disease issues in

xenotransplantation.

Place: Holiday Inn Bethesda, 8120

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Mary Groesch, PhD,

Executive Director, Secretary’s Advisory

Committee on Xenotransplantation, Office of

Science Policy, Rockledge I, Room 750,

Rockville, MD 20852, 301–496–9838.

Information is also available on the

Institute’s/Center’s home page:

www4.od.nih.gov/oba/xenomtg.htm, where

an agenda and any additional information for

the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.14, Intramural Research

Training Award; 93.187, Undergraduate

Scholarship Program for Individuals from

Disadvantaged Backgrounds; 93.22, Clinical

Research Loan Repayment Program for

Individuals from Disadvantaged

Backgrounds; 93.232, Loan Repayment

Program for Research Generally; 93.39,

Academic Research Enhancement Award;

93.936, NIH Acquired Immunodeficiency

Syndrome Research Loan Repayment

Program, National Institutes of Health, HHS)

Dated: May 16, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–12924 Filed 5–22–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel

Development of High-Yield Technologies for

Isolating Exfoliated Cells in Body Fluids.

Date: June 11, 2001.

Time: 8 am to 4 pm.

Agenda: To review and evaluate grant

applications.

Place: National Cancer Institute, 6130

Executive Blvd., Conference Room C,

Rockville, MD 20852.

Contact Person: Kenneth L. Bielat, PhD,

Scientific Review Administrator, Division of

Extramural Activities, National Cancer

Institute, National Institutes of Health, 6116

Executive Boulevard, Room 8043, Bethesda,

MD 20892, (301) 496–7576.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: May 15, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–12915 Filed 5–22–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel Cancer

Prevention Research Small Grants Program.

Date: June 19, 2001.

Time: 8 am to 5 pm.

Agenda: To review and evaluate grant

applications.

Place: Bethesda Marriott Suites, 6711

Democracy Boulevard, Bethesda, MD 20817.

Contact Person: Lalita D. Palekar, PhD,

Scientific Review Administrator, Special

Review, Referral and Resources Branch,

Division of Extramural Activities, National

Cancer Institute, National Institutes of

Health, 6116 Executive Boulevard, Room

8066, Bethesda, MD 20892–7405, (301) 496–

7575.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,